419 related articles for article (PubMed ID: 22133794)
41. Scleral patch grafts in the management of uveal and ocular surface tumors.
Barman M; Finger PT; Milman T
Ophthalmology; 2012 Dec; 119(12):2631-6. PubMed ID: 22858126
[TBL] [Abstract][Full Text] [Related]
42. Long-term follow-up after uveal melanoma charged particle therapy.
Char DH; Kroll SM; Castro J
Trans Am Ophthalmol Soc; 1997; 95():171-87; discussion 187-91. PubMed ID: 9440169
[TBL] [Abstract][Full Text] [Related]
43. Endoresection versus iodine-125 plaque brachytherapy for the treatment of choroidal melanoma.
Caminal JM; Mejia K; Masuet-Aumatell C; Arias L; Piulats JM; Gutierrez C; Pera J; Catala J; Rubio M; Arruga J
Am J Ophthalmol; 2013 Aug; 156(2):334-342.e1. PubMed ID: 23677135
[TBL] [Abstract][Full Text] [Related]
44. Survival, anatomic, and functional long-term results in choroidal and ciliary body melanoma after ruthenium brachytherapy (15 years' experience with beta-rays).
Rouberol F; Roy P; Kodjikian L; Gérard JP; Jean-Louis B; Grange JD
Am J Ophthalmol; 2004 May; 137(5):893-900. PubMed ID: 15126155
[TBL] [Abstract][Full Text] [Related]
45. Eye-wall resection.
Char DH; Miller T; Crawford JB
Trans Am Ophthalmol Soc; 2000; 98():153-9; discussion 159-61. PubMed ID: 11190019
[TBL] [Abstract][Full Text] [Related]
46. Conservative resection and adjuvant plaque brachytherapy for early-stage conjunctival melanoma.
Karim R; Conway RM
Clin Exp Ophthalmol; 2011; 39(4):293-8. PubMed ID: 21105970
[TBL] [Abstract][Full Text] [Related]
47. Plaque radiotherapy of uveal melanoma with predominant ciliary body involvement.
Gündüz K; Shields CL; Shields JA; Cater J; Freire JE; Brady LW
Arch Ophthalmol; 1999 Feb; 117(2):170-7. PubMed ID: 10037560
[TBL] [Abstract][Full Text] [Related]
48. Plaque radiotherapy for large posterior uveal melanomas (> or =8-mm thick) in 354 consecutive patients.
Shields CL; Naseripour M; Cater J; Shields JA; Demirci H; Youseff A; Freire J
Ophthalmology; 2002 Oct; 109(10):1838-49. PubMed ID: 12359604
[TBL] [Abstract][Full Text] [Related]
49. Factors associated with elevated intraocular pressure in eyes with iris melanoma.
Shields CL; Materin MA; Shields JA; Gershenbaum E; Singh AD; Smith A
Br J Ophthalmol; 2001 Jun; 85(6):666-9. PubMed ID: 11371484
[TBL] [Abstract][Full Text] [Related]
50. Comparison of episcleral plaque and proton beam radiation therapy for the treatment of choroidal melanoma.
Wilson MW; Hungerford JL
Ophthalmology; 1999 Aug; 106(8):1579-87. PubMed ID: 10442907
[TBL] [Abstract][Full Text] [Related]
51. Conservation treatment of the eye: Conformal proton reirradiation for recurrent uveal melanoma.
Marucci L; Lane AM; Li W; Egan KM; Gragoudas ES; Adams JA; Collier JM; Munzenrider JE
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1018-22. PubMed ID: 16376492
[TBL] [Abstract][Full Text] [Related]
52. Palladium-103 ophthalmic plaque radiation therapy for choroidal melanoma: 400 treated patients.
Finger PT; Chin KJ; Duvall G;
Ophthalmology; 2009 Apr; 116(4):790-6, 796.e1. PubMed ID: 19243829
[TBL] [Abstract][Full Text] [Related]
53. Radiotherapeutic and surgical management of iris melanoma: A review.
Popovic M; Ahmed IIK; DiGiovanni J; Shields CL
Surv Ophthalmol; 2017; 62(3):302-311. PubMed ID: 28062196
[TBL] [Abstract][Full Text] [Related]
54. Radiation complications and tumor control after 125I plaque brachytherapy for ocular melanoma.
Jensen AW; Petersen IA; Kline RW; Stafford SL; Schomberg PJ; Robertson DM
Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):101-8. PubMed ID: 16111577
[TBL] [Abstract][Full Text] [Related]
55. Periocular triamcinolone for prevention of macular edema after iodine 125 plaque radiotherapy of uveal melanoma.
Horgan N; Shields CL; Mashayekhi A; Teixeira LF; Materin MA; O'Regan M; Shields JA
Retina; 2008; 28(7):987-95. PubMed ID: 18698302
[TBL] [Abstract][Full Text] [Related]
56. [Iris melanomas. A retrospective study of 11 patients treated by surgical excision].
Cardine S; Labetoulle M; Kirsch O; Di Nolfo M; Offret H; Frau E
J Fr Ophtalmol; 2003 Jan; 26(1):31-7. PubMed ID: 12610407
[TBL] [Abstract][Full Text] [Related]
57. Conservation of eyes with choroidal melanoma by a multimodality approach to treatment: an audit of 1632 patients.
Damato B; Lecuona K
Ophthalmology; 2004 May; 111(5):977-83. PubMed ID: 15121377
[TBL] [Abstract][Full Text] [Related]
58. Histopathology of eyes enucleated after endoresection of choroidal melanoma.
Hadden PW; Hiscott PS; Damato BE
Ophthalmology; 2004 Jan; 111(1):154-60. PubMed ID: 14711728
[TBL] [Abstract][Full Text] [Related]
59. Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation.
Gündüz K; Günalp I; Yalçindağ N; Unal E; Taçyildiz N; Erden E; Geyik PO
Ophthalmology; 2004 Oct; 111(10):1917-24. PubMed ID: 15465557
[TBL] [Abstract][Full Text] [Related]
60. Local tumor control, visual acuity, and survival after hypofractionated stereotactic photon radiotherapy of choroidal melanoma in 212 patients treated between 1997 and 2007.
Dunavoelgyi R; Dieckmann K; Gleiss A; Sacu S; Kircher K; Georgopoulos M; Georg D; Zehetmayer M; Poetter R
Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):199-205. PubMed ID: 20675066
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]